Clinical Kidney Journal

Papers
(The TQCC of Clinical Kidney Journal is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Correction of profound hyponatraemia following rapid bolus therapy: effectiveness of the Barsoum–Levine formula based on the Edelman equation431
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations106
Breaking barriers: giving HOPE to people living with HIV and end-stage renal disease86
Acute kidney injury with hypernatremia and major adverse kidney events80
Mission P(D)ossible: peritoneal dialysis in difficult cases69
Effects of spironolactone on intradialytic hypertension: a multicentre, double-blind, randomized, crossover study56
Intravenous amino acid for kidney protection: current understanding and future perspectives52
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study52
Kidney function and bone mineral density in chronic kidney disease patients48
The spectrum of diseases, genetic landscape, and new mutation sites of hereditary cystic kidney disease46
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort43
Correcting hyponatraemia is associated with improved survival in hyponatraemic metastatic cancer patients43
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis42
Systematic reporting of medical kidney biopsies42
Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients37
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function37
Flank pain has a significant adverse impact on quality of life in ADPKD: the CYSTic-QoL study34
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus33
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective31
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR31
Outcomes of primary membranous nephropathy refractory to immunosuppressants30
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms30
Non-dilated obstructive nephropathy30
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients29
Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis28
Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression—real-world clinical practice28
Postoperative mid-to-long-term adverse event prediction model for patients receiving non-cardiac surgery: An extension of Simple Postoperative AKI RisK (SPARK) model27
Integrated primary and secondary care optimises the management of people with CKD - The LUCID project27
The impact of mild and moderate COVID-19 infection on the progression of kidney dysfunction in patients with IgA nephropathy27
Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose27
Recovery from kidney failure associated with chronic thromboembolic pulmonary hypertension following pulmonary thomboendarterectomy27
A puzzling renal Fanconi Syndrome27
The association of glucose metabolism and kidney function in middle-aged adults27
From Bytes to Bites: Application of Large Language Models to Enhance Nutritional Recommendations in CKD27
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease26
Long-Term Evaluation of the Timing of Corticosteroid Therapy in an IgA Nephropathy Cohort26
Subcutaneous Ofatumumab in Recurrent Focal Segmental Glomerulosclerosis Post Kidney Transplantation25
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome25
Serum bilirubin and kidney function: a Mendelian randomization study25
Relationship of serum lipid parameters with kidney function decline accompanied by systemic arterial stiffness: a retrospective cohort study25
Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease24
Kidney transplantation and gut microbiota24
Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes24
Estimating glomerular filtration in young people23
The predictive performance of the ANCA renal risk score in patients over 65 years of age with renal ANCA-associated vasculitis22
[18F] AlF-NOTA-FAPI-04 PET/CT for non-invasive assessment of tubular injury in kidney diseases22
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic22
Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidne22
Urinary RANTES and MCP-1 as noninvasive biomarkers for differential diagnosis and prediction of treatment response in acute interstitial nephritis22
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study22
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy22
Tolvaptan and the role of kidney aquaporin-2 abundance in managing volume overload in patients with CKD22
How to make a shared decision with older persons for end-stage kidney disease treatment: the added value of geronto-nephrology22
Frailty assessment as part of transplant listing: yes, no or maybe?21
Reply to ‘Kidney involvement in hereditary transthyretin amyloidosis: is there a role for cystatin C?’21
The hypokalaemia that came from the cold21
2009 CKD-EPI glomerular filtration rate estimation in Black individuals outside the United States: a systematic review and meta-analysis21
The use of plasma biomarker-derived clusters for clinicopathologic phenotyping: results from the Boston Kidney Biopsy Cohort21
The optimized anticoagulation strategy in prolonged hemodialysis20
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis20
Exploring the impact and utility of genomic sequencing in established CKD20
A phase IV, randomised, double-blind, controlled, parallel group trial to evaluate the effectiveness and safety of Balneum Plus versus emollient in the treatment of chronic kidney disease–associated p20
Management of de novo nephrolithiasis after kidney transplantation: a comprehensive review from the European Renal Association CKD-MBD working group20
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis19
Baseline proteinuria level and adverse outcomes in pregnant women with chronic kidney disease: new evidence and a note of caution19
Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort study19
Average creatinine–urea clearance: revival of an old analytical technique?19
The need for better donor engagement and outreach with legacy living kidney donors19
The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes19
Left-sided valvular heart disease in dialysis recipients: a single-centre observational study19
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with onl19
Modified creatinine index as a marker of skeletal muscle mass in peritoneal dialysis patients19
Moving on obesity treatment in CKD: inertia is unjustified18
Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria18
A deep learning system for retinal vessel calibre improves cardiovascular risk prediction in Asians with chronic kidney disease18
Differentiating primary and secondary FSGS using non-invasive urine biomarkers18
Inverse association between serum chloride levels and the risk of atrial fibrillation in chronic kidney disease patients18
Association between magnesium, erythropoietin resistance and mortality: the Japanese Dialysis Outcomes and Practice Patterns Study (J-DOPPS)18
Cystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study18
Sex and gender differences in health-related quality of life in individuals treated with incremental and conventional hemodialysis18
Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients18
Ten tips on how to manage obesity in the presence of CKD18
Clinicopathological prognostic stratification for proteinuria and kidney survival in IgA nephropathy: a Japanese prospective cohort study18
Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 201918
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype17
Risk of incident chronic kidney disease among patients with urolithiasis: a nationwide longitudinal cohort study17
Associations of MRI-derived kidney volume, kidney function, body composition and physical performance in ≈38 000 UK Biobank participants: a population-based observational study17
Age- and time-dependent increases in incident anti-glomerular basement membrane disease: a nationwide cohort study17
Urine metabolite changes after cardiac surgery predict acute kidney injury17
The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients17
Plain language summary of a study looking at the effect of empagliflozin treatment in patients with chronic kidney disease17
Combined evaluation of glomerular phospholipase A2 receptor and immunoglobulin G subclass in membranous nephropathy17
Can exercise improve outcomes for frail haemodialysis patients?16
The role of genomic disorders in chronic kidney failure of undetermined aetiology ≤50 years16
Toward acid- and heparin-free dialysis: the regional anticoagulation approach16
Loin pain haematuria syndrome 1967–2020: a review16
Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis16
Pathogenic heterozygous TRPM7 variants and hypomagnesemia with developmental delay16
Acute kidney injury after non-cardiac major surgery: has it reduced?16
Unraveling complexity: morbidity factors in elderly kidney transplant recipients16
CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction16
Bidirectional association of sleep disorders with chronic kidney disease: a systematic review and meta-analysis16
Elimination and penetration of amikacin into urine in patients with decreased glomerular filtration rate16
31P-MRS, molecular level imaging for assessing muscular mitochondrial dysfunction in chronic kidney disease15
Challenges of defining renal response in ANCA-associated vasculitis: call to action?15
Primary hyperoxaluria: the adult nephrologist's point of view15
Primary hyperoxaluria type 1: pathophysiology and genetics15
Complement-activating conditions as potential triggers of pregnancy-related atypical haemolytic uraemic syndrome15
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres15
Welcome editorial by the new CKJ Editor-in-Chief: Facing the future of CKJ with enthusiasm!15
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury15
Serum anti-CRP antibodies differentiate etiology and predict relapse in acute tubulointerstitial nephritis15
Baxter Physioneal, Extraneal, Nutrineal (PEN) and Dianeal solution bags can be accidentally connected to Fresenius peritoneal dialysis catheter extensions in a non-sterile manner15
Novel somatic PBX1 mosaicism likely masking syndromic CAKUT in an adult with bilateral kidney hypoplasia15
The incidence of cancer recurrence and new cancer following commencement of dialysis15
Qualitative approach to better understand the trajectory of patients with early and moderate stage CKD15
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging15
Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing14
Increased expression of SCARF genes favoring SARS-CoV-2 infection in key target organs in CKD14
Genetic evaluation of paediatric nephrocalcinosis: phenotype-driven genetic panels reveal a rare diagnosis14
Sustained humoral response 6 months after the anti-SARS-CoV-2 mRNA-BNT162b2 vaccine in haemodialysis patients: should booster vaccine doses be given to all patients at the same time?14
Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients14
Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single-centre experience in 25 patients14
More dissimilarities than affinities between DNAJB11-PKD and ADPKD14
Effect of music therapy intervention on anxiety and pain during percutaneous renal biopsy: a randomized controlled trial14
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy14
Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study14
Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin14
The hidden diabetic kidney disease in a university hospital-based population: a real-world data analysis14
Pre-emptive use of glucose 5% as the standard drug solvent reduces hypernatremia in critically ill patients14
Early and late ANCA vasculitis relapses after kidney transplantation may have different presentations13
Fabry disease with atypical phenotype identified by massively parallel sequencing in early-onset kidney failure13
Management of acute renal replacement therapy in critically ill cirrhotic patients13
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab13
Switching from immediate- to extended-release cysteamine in patients with nephropathic cystinosis: from clinical trials to clinical practice13
Regional variation in tolvaptan prescribing across England: national data and retrospective evaluation from an expert centre13
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study13
Impact of peritoneal dialysis strategy on technique and patient survival12
Focal segmental glomerulosclerosis associated with the use of the IL-23 inhibitor guselkumab12
Tofacitinib for the treatment of refractory immune checkpoint inhibitor-associated immune nephritis12
Compound heterozygous variants of ANKFY1 in a child with infantile-onset proteinuria and movement disorder12
PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations12
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study12
Kidney health for all: bridging the gap in kidney health education and literacy12
Development of a multimodal kidney age prediction based on automatic segmentation CT image in patients with normal renal function12
Microemboli induced by air bubbles may be deposited in organs as a consequence of contamination during medical care12
Single-nephron assessment of urate excretion in patients with IgA nephropathy12
Thiazides in chronic kidney disease: “back to the future”12
Achieving consensus on psychosocial and physical rehabilitation management for people living with kidney disease12
Individualizing immunosuppressive therapy decision in immunoglobulin A nephropathy and application in a Southeast Asian cohort12
Early growth response 1 as a podocyte injury marker in human glomerular diseases12
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials12
Estimating glomerular filtration rate with cystatin C: a systematic comparison of the new EKFC and the CKD-EPI equation12
Hypoxia during maintenance hemodialysis—the critical role of pH11
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art11
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?11
Who killed Bruce Lee? The hyponatraemia hypothesis11
Kidney glomerular filtration rate plasticity after transplantation11
Coturnism as a cause of deadly rhabdomyolysis in Biblical times11
Monoclonal gammopathy of renal significance presenting with cryoglobulinaemia type I associated severe thrombotic microangiopathy11
Central volume shift in acute heart failure revealed by blood volume monitoring during haemodialysis11
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study11
Multitargeted interventions to reduce dialysis-induced systemic stress11
Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia11
Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease11
Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis11
Push toward pre-emptive kidney transplantation – for sure?11
The kidney in hantavirus infection—epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management11
Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity11
Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D11
Short-term peritoneal rest reduces peritoneal solute transport rate and increases ultrafiltration in high/high average transport peritoneal dialysis patients: a crossover randomized controlled trial11
Klotho and lean mass as novel cardiovascular risk factors in hemodialysis patients11
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patient11
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey11
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study11
Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study11
Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?11
Non-contrast preoperative MRI for determining renal perfusion and visualizing renal arteries in potential living kidney donors at 1.5 Tesla10
Gut-immune axis and cardiovascular risk in chronic kidney disease10
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity10
Efficacy and safety of endothelin A receptor antagonists in IgA nephropathy: a systematic review and meta-analysis10
Life beyond antibodies: quality of life after desensitization in kidney transplantation10
Biomarkers in clinical epidemiology studies10
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease10
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies10
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term10
The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison10
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression10
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study10
Development and validation of a measure to assess patient experience of needling of arteriovenous fistulas or grafts for haemodialysis access: the NPREM10
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal10
Use of rituximab and plasma exchange in treatment and prophylaxis of recurrent FSGS10
Incidence of and risk factors of chronic kidney disease: results of a nationwide study in Iceland10
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study10
Searching in the maze: sodium–glucose cotransporter-2 inhibitors in kidney transplant recipients to improve survival10
The effects of a physical exercise program in Chinese kidney transplant recipients: a prospective randomised controlled trial10
The impact of gastric acid suppressants on peritonitis risk in peritoneal dialysis patients: a systematic review and meta-analysis10
From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes10
Changes in cardiac troponins during hemodialysis depend on hemodialysis membrane and modality: a randomized crossover trial10
RICORS2040: the need for collaborative research in chronic kidney disease9
The ERA Registry Annual Report 2020: a summary9
TIMP-2 and IGFBP7 in human kidney biopsies in renal disease9
Kidney Donor Profile Index and allograft outcomes: interactive effects of estimated post-transplant survival score and ischaemic time9
Genetic vs non-genetic kidney disease: prognosis insights from a multi-cohort study9
Comparative Outcomes of Surgical vs. Percutaneous Arteriovenous Fistulas: A Prospective Study9
An introduction to inverse probability of treatment weighting in observational research9
CD163 detection in immune check-point inhibitors-related acute interstitial nephritis9
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA20239
Aging and chronic kidney disease: epidemiology, therapy, management and the role of immunity9
Application of artificial intelligence to chronic kidney disease mineral bone disorder9
Peritoneal dialysis for acute kidney injury: back on the front-line9
Robot-assisted kidney transplantation: an update9
Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?9
Does low-dose spironolactone increase cardiovascular protection in patients with chronic kidney disease?9
Long-term follow-up of IgA nephropathy: clinicopathological features and predictors of outcomes9
Glomerular endothelial injury following vaccination for SARS-CoV-29
Backtracking cryptic recurrence of esophageal cancer from membranous nephropathy: the detection of glomerular NELL-1 and IgG49
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy9
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials9
Effect of serum creatinine difference between the Jaffe and the enzymatic method on kidney disease detection and staging9
International validation of a pre-transplant risk assessment tool for graft survival in pediatric kidney transplant recipients9
Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease9
A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients9
EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors9
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease9
Vitamin D: are all compounds equal?9
Pathophysiology of chronic kidney disease–mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis9
Introduction to new CKJ section: In Context – in collaboration with YNP9
Kidney involvement in Wilson's disease: a review of the literature9
Hypertension in living kidney donors: understanding the real risk9
Prolonged detection of SARS-CoV-2 RNA in chronic haemodialysis patients9
Impact of type of vascular access on clinical outcomes in peritoneal dialysis patients transitioning to haemodialysis: an ANZDATA study9
Vitamin D therapy in chronic kidney disease: a critical appraisal of clinical trial evidence9
10 tips on how to manage severe arrhythmia in hemodialysis patients9
Point-of-care ultrasound training in nephrology: a position statement by the International Alliance for POCUS in Nephrology9
Management of fracture risk in CKD—traditional and novel approaches9
Increased mortality after kidney transplantation in mildly frail recipients9
The Emboless® venous chamber efficiently reduces air bubbles: a randomized study of chronic hemodialysis patients8
Association of obesity with 3-month mortality in kidney failure patients with COVID-198
Crystalline podocytopathy and tubulopathy linked to kappa light chain deposits in a context of smoldering multiple myeloma8
Interaction effect between fasting plasma glucose and lipid profiles on mortality of peritoneal dialysis patients8
Wasp stings and plasma exchange8
Effect of ethnicity and socioeconomic deprivation on uptake of renal supportive care and dialysis decision-making in older adults8
Performance of real-time PCR in suspected haemodialysis catheter-related bloodstream infection: a proof-of-concept study8
Age and the eGFR-dependent risk for adverse clinical outcomes8
Donor liquid biopsy and outcomes in kidney transplantation8
Does de novo malignancy heighten the risk of rejection in kidney transplant recipients?8
Renal function is highly associated with podiatric risk in diabetic patients8
Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients8
Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease8
0.34064984321594